Glassman Wealth Services Prothena Corp Public LTD CO Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$7.54 - $15.77 $7 - $15	-1 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$7.48 - $17.01 $7 - $17	1 New	1 $0
Q4 2018 Feb 06, 2019	SELL	$8.73 - $13.74 $244 - $384	-28 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.7 - $15.79 $355 - $442	28 New	28 $0

186

42.8M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $646M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.